Literature DB >> 8909203

Occult macular dystrophy.

Y Miyake1, M Horiguchi, N Tomita, M Kondo, A Tanikawa, H Takahashi, S Suzuki, H Terasaki.   

Abstract

PURPOSE: Occult macular dystrophy is a hereditary macular dystrophy without any visible abnormality of the fundus or abnormality indicated by fluorescein angiography even when visual acuity is decreased. Normal full-field electroretinogram in both cone and rod components with abnormal focal macular cone electroretinogram is the key to diagnosing this disorder. The purpose of this study was to identify the function of the macular rods and to provide detailed clinical findings in occult macular dystrophy.
METHODS: Thirteen patients from eight families were examined. The fundi of 12 patients were essentially normal (occult macular dystrophy), and the oldest patient in one family disclosed bull's eye maculopathy. In the 12 patients, including the patient with bull's eye maculopathy, the profiles of cone and rod absolute thresholds were performed across the 60-degree horizontal meridian of the posterior pole.
RESULTS: All 12 patients showed cone sensitivity loss only in the macular area. Six relatively young patients revealed normal rod sensitivity, whereas six older patients showed borderline rod sensitivity or abnormal rod sensitivity in the macular area.
CONCLUSIONS: The pathology of occult dystrophy involves either only the macular cone system or macular cone and rod systems without any visible abnormality. This difference of the pathology suggests a different clinical entity or a different stage of occult macular dystrophy.

Entities:  

Mesh:

Year:  1996        PMID: 8909203     DOI: 10.1016/s0002-9394(14)70482-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  34 in total

1.  Clinical applications of multifocal electroretinography.

Authors:  U Kretschmann; M Bock; R Gockeln; E Zrenner
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

2.  Assessment of local cone on- and off-pathway function using multifocal ERG technique.

Authors:  M Kondo; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  Multifocal ERG changes before and after macular hole surgery.

Authors:  M Moschos; M Apostolopoulos; J Ladas; P Theodossiadis; J Malias; M Moschou; A Papaspirou; G Theodossiadis
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

4.  Occult macular dystrophy in an 11 year old boy.

Authors:  M Kondo; S Ueno; C-H Piao; Y Ito; H Terasaki; Y Miyake
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

5.  Slowly progressive non-neoplastic autoimmune-like retinopathy.

Authors:  Kouichi Ohta; Takanobu Kikuchi; Noriko Yoshida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-13       Impact factor: 3.117

6.  A case of unilateral occult maculopathy with normal-tension glaucoma.

Authors:  Kazuki Hotta
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

Review 7.  Occult macular dystrophy.

Authors:  Yozo Miyake; Kazushige Tsunoda
Journal:  Jpn J Ophthalmol       Date:  2015-02-10       Impact factor: 2.447

8.  Comparison of mfERG waveform components and implicit time measurement techniques for detecting functional change in early diabetic eye disease.

Authors:  Marilyn E Schneck; Marcus A Bearse; Ying Han; Shirin Barez; Carl Jacobsen; Anthony J Adams
Journal:  Doc Ophthalmol       Date:  2004-05       Impact factor: 2.379

9.  Characterizing the phenotype and genotype of a family with occult macular dystrophy.

Authors:  Connie J Chen; Hendrik P N Scholl; David G Birch; Takeshi Iwata; Neil R Miller; Morton F Goldberg
Journal:  Arch Ophthalmol       Date:  2012-12

10.  A 43-year-old man with reduced visual acuity and normal fundus: occult macular dystrophy--case report.

Authors:  Wojciech Lubiński; Wojciech Gosławski; Krzysztof Penkala; Monika Drobek-Słowik; Danuta Karczewicz
Journal:  Doc Ophthalmol       Date:  2007-10-23       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.